- Citations, last 5 years
- 141
- Works, last 5 years
- 23
- h-index
- 29
- Scientists listed
- 4
- Grants since 2016
- 4
Grants received
2020–2023 · research · R01
A randomized, placebo-controlled, double-blind study to evaluate safety and efficacy of NDX-1017 treatment in Alzheimer's dementia patients
Charles Bernick · Athira Pharma (United States) · funded by National Institutes of Health
2020–2023 · research · R01
A randomized, placebo-controlled, double-blind study to evaluate safety and efficacy of NDX-1017 treatment in Alzheimer's dementia patients
Charles Bernick · Athira Pharma (United States) · funded by National Institutes of Health
2020–2023 · research · R01
A randomized, placebo-controlled, double-blind study to evaluate safety and efficacy of NDX-1017 treatment in Alzheimer's dementia patients
Charles Bernick · Athira Pharma (United States) · funded by National Institutes of Health
2018 · research · PTC-R
Phase 2a Alzheimer’s trials of a novel neurotrophic activator, NDX-1017.
Xue Hua · Athira Pharma (United States) · funded by Alzheimer's Association